These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11429029)

  • 1. Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection.
    McCaughan GW; Zekry A
    Transpl Infect Dis; 2000 Dec; 2(4):166-85. PubMed ID: 11429029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathogenesis of hepatitis C virus in the immunosuppressed host.
    Einav S; Koziel MJ
    Transpl Infect Dis; 2002 Jun; 4(2):85-92. PubMed ID: 12220245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel strategies for preventing viral hepatitis C recurrence after liver transplantation].
    Stoll-Keller F; Fafi-Kremer S; Wolf P; Doffoël M; Baumert T
    Bull Acad Natl Med; 2008 Nov; 192(8):1657-67; discussion 1667-8. PubMed ID: 19445379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation.
    McCaughan GW; Zekry A
    Liver Transpl; 2003 Nov; 9(11):S21-7. PubMed ID: 14586891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis, diagnosis and management of hepatitis C.
    Boyer N; Marcellin P
    J Hepatol; 2000; 32(1 Suppl):98-112. PubMed ID: 10728798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virology and pathogenesis of hepatitis C virus recurrence.
    Ramírez S; Pérez-Del-Pulgar S; Forns X
    Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness of direct acting antivirals for treatment of hepatitis C virus in patients with solid organ transplantation.
    Mansour M; Hill L; Kerr J
    Transpl Infect Dis; 2018 Dec; 20(6):e12972. PubMed ID: 30080955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination.
    Kasarala G; Choi S; Lopez K; Britt RB; Boatright C; Tillmann HL
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29064152
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppression, liver injury and post-transplant HCV recurrence.
    Ciesek S; Wedemeyer H
    J Viral Hepat; 2012 Jan; 19(1):1-8. PubMed ID: 22187942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New modalities in the treatment of HCV in pre and post - transplantation setting.
    Araz F; Durand CM; Gürakar A
    Turk J Gastroenterol; 2015 May; 26(3):204-13. PubMed ID: 26006192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living donor liver transplantation to patients with hepatitis C virus cirrhosis.
    Sugawara Y; Makuuchi M
    World J Gastroenterol; 2006 Jul; 12(28):4461-5. PubMed ID: 16874855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes.
    McCaughan GW; Shackel NA; Bertolino P; Bowen DG
    Transplantation; 2009 Apr; 87(8):1105-11. PubMed ID: 19384153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens.
    Papatheodoridis GV; Barton SG; Andrew D; Clewley G; Davies S; Dhillon AP; Dusheiko G; Davidson B; Rolles K; Burroughs AK
    Gut; 1999 Sep; 45(3):427-34. PubMed ID: 10446114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of immunosuppression and chemotherapy on reactivation of viral hepatitis.
    Fallahian F; Alavian SM; Fallahian V; Zamani F
    Saudi J Kidney Dis Transpl; 2010 Jul; 21(4):621-7. PubMed ID: 20587863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent hepatitis C following liver transplant: diagnosis, natural history, and therapeutic options.
    Saab S; Wang V
    J Clin Gastroenterol; 2003 Aug; 37(2):155-63. PubMed ID: 12869888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hepatitis C virus infection in the setting of liver transplantation.
    Rodriguez-Luna H; Vargas HE
    Liver Transpl; 2005 May; 11(5):479-89. PubMed ID: 15838917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation.
    Berenguer M; Charco R; Manuel Pascasio J; Ignacio Herrero J
    Liver Int; 2012 May; 32(5):712-31. PubMed ID: 22221843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus and organ transplantation.
    Fishman JA; Rubin RH; Koziel MJ; Periera BJ
    Transplantation; 1996 Jul; 62(2):147-54. PubMed ID: 8755808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.